VERSANT HCV RNA QUALITATIVE ASSAY AND THE APTIMA HCV RNA QUALITATIVE ASSAY
FDA premarket approval P020011/S001 · decided 2009-05-22
Approval details
- PMA number
- P020011
- Supplement
- S001
- Supplement type
- 30-Day Notice
- Supplement reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Trade name
- VERSANT HCV RNA QUALITATIVE ASSAY AND THE APTIMA HCV RNA QUALITATIVE ASSAY
- Generic name
- Assay, hybridization and/or nucleic acid amplification for detection of hepatitis c rna,hepatitis c virus
- Applicant
- Gen-Probe
- Date received
- 2009-05-01
- Decision date
- 2009-05-22
- Days to decision
- 21 days
- Decision code
- OK30
- Product code
- MZP
- Advisory committee
- Microbiology
- Expedited review
- No
- Location
- San Diego, CA
- Statement
- CHANGE OF THE ACTIVATOR USED IN THE SYNTHESIS OF DNA OLIGONUCLEOTIDES FROM 1-H TETRAZOLE TO 5-ETHYLTHIO 1-H TETRAZOLE (ETT) AND THE ADDITION OF SIGMA-ALDRICH (SAFC) AS A SECONDARY SUPPLIER OF THE NEW ACTIVATOR (ETT).
Class III intelligence, same tools
PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.